Tower Research Capital (TRC)’s iShares iBonds Dec 2026 Term Corporate ETF IBDR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$190K Buy
7,829
+5,562
+245% +$135K ﹤0.01% 1664
2025
Q4
$54.9K Sell
2,267
-13,485
-86% -$327K ﹤0.01% 2350
2025
Q3
$383K Buy
+15,752
New +$381K 0.01% 1029
2017
Q2
Sell
-200
Closed -$5K 3032
2017
Q1
$5K Buy
+200
New +$4.79K ﹤0.01% 2198

Other funds holding IBDR

Tower Research Capital (TRC)'s IBDR Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its iShares iBonds Dec 2026 Term Corporate ETF (IBDR) stake by 245% in Q1 2026, buying an estimated $135K and bringing the position to 7,829 shares worth $190K. The position accounts for ﹤0.01% of the portfolio, ranked #1664.

Tower Research Capital (TRC) first reported a position in IBDR in Q1 2017 and has held it in 4 quarters since. The position peaked at $383K in Q3 2025. 439 funds tracked by Wall St. Rank hold IBDR as of Q1 2026.

  • Tower Research Capital (TRC) held 7,829 shares of iShares iBonds Dec 2026 Term Corporate ETF worth $190K as of Q1 2026.
  • Tower Research Capital (TRC) bought 5,562 iShares iBonds Dec 2026 Term Corporate ETF shares in Q1 2026, an estimated $135K.
  • iShares iBonds Dec 2026 Term Corporate ETF made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #1664 holding.
  • Tower Research Capital (TRC) first reported a position in iShares iBonds Dec 2026 Term Corporate ETF in Q1 2017 and has held it in 4 quarters since.
  • Tower Research Capital (TRC)'s iShares iBonds Dec 2026 Term Corporate ETF position peaked at $383K in Q3 2025.
  • 439 funds tracked by Wall St. Rank held iShares iBonds Dec 2026 Term Corporate ETF as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.